deltatrials
Completed PHASE3 NCT00000143

Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)

Sponsor: Johns Hopkins Bloomberg School of Public Health

Conditions Cytomegalovirus Retinitis HIV Infections
Interventions Cidofovir intravenous Ganciclovir implant and oral ganciclovir
Updated 7 times since 2017 Last updated: Feb 18, 2016 Started: May 31, 1997 Primary completion: Jun 30, 2000 Completion: Jun 30, 2000

Listed as NCT00000143, this PHASE3 trial focuses on Cytomegalovirus Retinitis and HIV Infections and remains completed. Sponsored by Johns Hopkins Bloomberg School of Public Health, it has been updated 7 times since 1997, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE3

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE3

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

May 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Johns Hopkins Bloomberg School of Public Health
Data source: Johns Hopkins Bloomberg School of Public Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States, Baltimore, United States, Boston, United States, Chapel Hill, United States, Chicago, United States, Houston, United States, Indianapolis, United States, Irvine, United States, La Jolla, United States, Los Angeles, United States and 6 more location s